Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

591
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
591
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

511
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
511
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

725
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
725

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defibrillator generator replacements in patients with left ventricular assist device support: The risks of hematoma and infection.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2022
Same author

Mechanical unloading by miniature axial flow pumps in late cardiac allograft failure due to acute rejection.

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs·2021
Same author

Three-stage treatment of late mediastinitis after implantation of left ventricular assist device.

Medicina intensiva·2016
Same author

[Ventricular long-term support with implantable continuous flow pumps: on the way to a gold standard in the therapy of terminal heart failure].

Herz·2015
Same author

Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices.

Minerva anestesiologica·2012
Same author

[Improvements in implantable mechanical circulatory support systems : literature overview and update].

Herz·2011
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[On pathogenesis of coronary heart disease].

Zeitschrift fur Kardiologie·2016
Same journal

An overview of the evolution of the atherosclerotic plaque: from fatty streak to plaque rupture and thrombosis.

Zeitschrift fur Kardiologie·2016
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[Reconstructive surgery of the aortic root].

Zeitschrift fur Kardiologie·2016
See all related articles

Related Experiment Video

Updated: Mar 19, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.7K

[Progress and perspectives in mechanical circulatory support].

M Loebe1, E Potapov1, T Drews1

  • 1Deutsches Herzzentrum Berlin, Augustenburger Platz 1, D-1333 Berlin, E-mail: loebe@dhzb.de, Germany.

Zeitschrift Fur Kardiologie
|June 21, 2016
PubMed
Summary
This summary is machine-generated.

Mechanical circulatory support devices, initially for permanent heart replacement, now primarily serve as a bridge to heart transplantation. Experience since 1987 highlights patient selection, care, and device maintenance, with potential for myocardial recovery.

Keywords:
Key words Heart assist devices – heart failure – myocarcial recovery

More Related Videos

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

10.1K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.2K

Related Experiment Videos

Last Updated: Mar 19, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.7K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

10.1K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.2K

Area of Science:

  • Cardiology and Cardiovascular Surgery
  • Biomedical Engineering

Context:

  • Mechanical circulatory support (MCS) devices were initially designed for permanent heart replacement.
  • Currently, the primary application of MCS is as a bridge to heart transplantation.
  • Extensive experience has been accumulated since 1987 regarding the use of these devices.

Purpose:

  • To present institutional experience with MCS devices, focusing on patient selection, post-implant care, and device maintenance.
  • To report on the use of a newly developed implantable axial flow pump.
  • To discuss the feasibility and economic aspects of permanent MCS support.

Summary:

  • Over 450 patients have received MCS implants at the institution.
  • MCS can facilitate recovery from secondary organ failure.
  • Some patients experience myocardial remodeling and improved heart function with MCS.

Impact:

  • Provides valuable insights into the practical application and management of MCS devices.
  • Evaluates a novel axial flow pump for circulatory support.
  • Contributes to the understanding of long-term MCS strategies and their associated costs.